MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41586-020-2607-z

Медицинская библиотека · Nature · 2020

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Mercado Noe B, Zahn Roland, Wegmann Frank, Loos Carolin, Chandrashekar Abishek, Yu Jingyou, Liu Jinyan, Peter Lauren, McMahan Katherine, Tostanoski Lisa H, He Xuan, Martinez David R, Rutten Lucy, Bos Rinke, van Manen Danielle, Vellinga Jort, Custers Jerome, Langedijk Johannes P, Kwaks Ted, Bakkers Mark J G, Zuijdgeest David, Rosendahl Huber Sietske K, Atyeo Caroline, Fischinger Stephanie, Burke John S, Feldman Jared, Hauser Blake M, Caradonna Timothy M, Bondzie Esther A, Dagotto Gabriel, Gebre Makda S, Hoffman Emily, Jacob-Dolan Catherine, Kirilova Marinela, Li Zhenfeng, Lin Zijin, Mahrokhian Shant H, Maxfield Lori F, Nampanya Felix, Nityanandam Ramya, Nkolola Joseph P, Patel Shivani, Ventura John D, Verrington Kaylee, Wan Huahua, Pessaint Laurent, Van Ry Alex, Blade Kelvin, Strasbaugh Amanda, Cabus Mehtap, Brown Renita, Cook Anthony, Zouantchangadou Serge, Teow Elyse, Andersen Hanne, Lewis Mark G, Cai Yongfei, Chen Bing, Schmidt Aaron G, Reeves R Keith, Baric Ralph S, Lauffenburger Douglas A, Alter Galit, Stoffels Paul, Mammen Mathai, Van Hoof Johan, Schuitemaker Hanneke, Barouch Dan H

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1-8. For global deployment and pandemic control, a vaccine that requires only a single immunization would be optimal. Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in non-human primates. Fifty-two rhesus macaques (Macaca mulatta) were immunized with Ad26 vectors that encoded S variants or sham control, and then challenged with SARS-CoV-2 by the intranasal and intratracheal routes9,10. The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs after SARS-CoV-2 challenge. Titres of vaccine-elicited neutralizing antibodies correlated with protective efficacy, suggesting an immune correlate of protection. These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in non-human primates. The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials.

Для цитирования: Mercado Noe B, Zahn Roland, Wegmann Frank, Loos Carolin, Chandrashekar Abishek, Yu Jingyou, Liu Jinyan, Peter Lauren, McMahan Katherine, Tostanoski Lisa H, He Xuan, Martinez David R, Rutten Lucy, Bos Rinke, van Manen Danielle, Vellinga Jort, Custers Jerome, Langedijk Johannes P, Kwaks Ted, Bakkers Mark J G, Zuijdgeest David, Rosendahl Huber Sietske K, Atyeo Caroline, Fischinger Stephanie, Burke John S, Feldman Jared, Hauser Blake M, Caradonna Timothy M, Bondzie Esther A, Dagotto Gabriel, Gebre Makda S, Hoffman Emily, Jacob-Dolan Catherine, Kirilova Marinela, Li Zhenfeng, Lin Zijin, Mahrokhian Shant H, Maxfield Lori F, Nampanya Felix, Nityanandam Ramya, Nkolola Joseph P, Patel Shivani, Ventura John D, Verrington Kaylee, Wan Huahua, Pessaint Laurent, Van Ry Alex, Blade Kelvin, Strasbaugh Amanda, Cabus Mehtap, Brown Renita, Cook Anthony, Zouantchangadou Serge, Teow Elyse, Andersen Hanne, Lewis Mark G, Cai Yongfei, Chen Bing, Schmidt Aaron G, Reeves R Keith, Baric Ralph S, Lauffenburger Douglas A, Alter Galit, Stoffels Paul, Mammen Mathai, Van Hoof Johan, Schuitemaker Hanneke, Barouch Dan H. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.. Nature. 2020. DOI: 10.1038/s41586-020-2607-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.